folic acid has been researched along with Neuroendocrine Tumors in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christoph, DC; Hager, T; Mairinger, FD; Schmid, KW; Vollbrecht, C; Walter, RF; Werner, R; Wohlschlaeger, J | 1 |
| Bhargava, P; Casey, C; Chan, JA; Clark, JW; Earle, CC; Kulke, MH; Regan, E; Stuart, K; Zhu, AX | 1 |
1 trial(s) available for folic acid and Neuroendocrine Tumors
| Article | Year |
|---|---|
Phase II study of pemetrexed in patients with advanced neuroendocrine tumors.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Dexamethasone; Female; Folic Acid; Glutamates; Guanine; Humans; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Pemetrexed; Survival; Treatment Outcome; Vitamin B 12; Vitamin B Complex | 2010 |
1 other study(ies) available for folic acid and Neuroendocrine Tumors
| Article | Year |
|---|---|
Folic-acid metabolism and DNA-repair phenotypes differ between neuroendocrine lung tumors and associate with aggressive subtypes, therapy resistance and outcome.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Large Cell; DNA Repair Enzymes; Drug Resistance, Neoplasm; Female; Folate Receptor 1; Folic Acid; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Prognosis; Small Cell Lung Carcinoma; Survival Rate; Young Adult | 2016 |